BILITE: a Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacy
From MaRDI portal
Publication:6617390
DOI10.1002/SIM.8733zbMATH Open1546.62285MaRDI QIDQ6617390
Author name not available (Why is that?)
Publication date: 10 October 2024
Published in: (Search for Journal in Brave)
No records found.
No records found.
This page was built for publication: BILITE: a Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6617390)